Jacobs Levy Equity Management’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-523,865
| Closed | -$246K | – | 1314 |
|
|
2016
Q1 | $246K | Buy |
523,865
+50,157
| +11% | +$23.6K | 0.01% | 927 |
|
|
2015
Q4 | $323K | Buy |
473,708
+116,068
| +32% | +$79.1K | 0.01% | 641 |
|
|
2015
Q3 | $347K | Buy |
357,640
+95,500
| +36% | +$92.7K | 0.01% | 632 |
|
|
2015
Q2 | $315K | Sell |
262,140
-51,717
| -16% | -$62.1K | 0.01% | 647 |
|
|
2015
Q1 | $333K | Buy |
313,857
+21,100
| +7% | +$22.4K | 0.01% | 637 |
|
|
2014
Q4 | $319K | Buy |
292,757
+56,200
| +24% | +$61.2K | 0.01% | 675 |
|
|
2014
Q3 | $255K | Buy |
+236,557
| New | +$255K | ﹤0.01% | 712 |
|
|
2014
Q2 | – | Sell |
-198,536
| Closed | -$204K | – | 1005 |
|
|
2014
Q1 | $204K | Sell |
198,536
-23,088
| -10% | -$23.7K | ﹤0.01% | 820 |
|
|
2013
Q4 | $257K | Buy |
221,624
+36,736
| +20% | +$42.6K | ﹤0.01% | 835 |
|
|
2013
Q3 | $311K | Buy |
184,888
+92,774
| +101% | +$156K | 0.01% | 787 |
|
|
2013
Q2 | $184K | Buy |
+92,114
| New | +$184K | ﹤0.01% | 899 |
|